ClinicalTrials.govpublic full text
Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)
cytomegalovirus cell mediated immunity, stem cell transplantation, hematopoietic, stem cell transplantation, cytomegalovirus, letermovir, prophylaxis, cytomegalovirus immunity, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992798
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.